AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases
August 03, 2015 at 04:23 AM EDT
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca (NYSE: AZN) today announced a strategic collaboration to discover and develop ...
